首页> 美国卫生研究院文献>Proceedings (Baylor University. Medical Center) >Focal cutaneous squamous cell carcinoma following radium-223 extravasation
【2h】

Focal cutaneous squamous cell carcinoma following radium-223 extravasation

机译:镭-223外渗后局灶性皮肤鳞状细胞癌

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Long-term sequelae due to extravasation of intravenous radioisotopes resulting in radiation injuries are rarely reported. As the use of radioactive isotopes for the treatment of osteoblastic metastases increases, information regarding the prevention, treatment, and long-term monitoring of suspected extravasation injury will become increasingly important. We present a patient with no previous history of skin cancer who developed an aggressive cutaneous squamous cell carcinoma at the site of prior radium-223 extravasation. We recommend that patients who experience extravasation of therapeutic radioisotopes be monitored by dermatologists for long-term sequelae. Cutaneous squamous cell carcinoma should be recognized as a rare but potential adverse event following cutaneous extravasation of radium-223 and is likely a side effect that is severely underreported.
机译:很少报道由于静脉内放射性同位素扩散导致放射损伤的长期后遗症。随着放射性同位素用于成骨细胞转移的治疗的增加,有关预防,治疗和长期监测可疑外渗损伤的信息将变得越来越重要。我们介绍了一个既往没有皮肤癌病史的患者,该患者在先前镭223的外渗部位发展为侵袭性皮肤鳞状细胞癌。我们建议皮肤科医生对经历治疗性放射性同位素外渗的患者进行长期后遗症监测。皮肤鳞状细胞癌应被认为是镭223皮肤外渗后的一种罕见但潜在的不良事件,并且可能是严重未报告的副作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号